MedPath

Across Co.,Ltd.

πŸ‡°πŸ‡·South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus

Phase 3
Completed
Conditions
Correction of Nasolabial Folds
Interventions
Device: Dermalax Implant Plus
Device: Restylane Sub-Q
First Posted Date
2014-07-02
Last Posted Date
2014-07-08
Lead Sponsor
Across Co., Ltd.
Target Recruit Count
60
Registration Number
NCT02179606
Locations
πŸ‡°πŸ‡·

Chung-ang University Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Eulji General Hospital, Seoul, Korea, Republic of

Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds

Phase 3
Completed
Conditions
Correction of Nasolabial Folds
Interventions
Device: Dermalax(Deep)
Device: Restylane
First Posted Date
2014-07-02
Last Posted Date
2014-07-02
Lead Sponsor
Across Co., Ltd.
Target Recruit Count
66
Registration Number
NCT02179619
Locations
πŸ‡°πŸ‡·

Chung-ang University Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Eulji General Hospital, Seoul, Korea, Republic of

Β© Copyright 2025. All Rights Reserved by MedPath